Françoise Vuillier

Summary

Affiliation: Institut Pasteur
Country: France

Publications

  1. ncbi request reprint Functional monocyte-derived dendritic cells can be generated in chronic lymphocytic leukaemia
    F Vuillier
    Unité d Immuno Hématologie et d Immunopathologie, Institut Pasteur, 28 rue du Dr Roux, F 75724 Paris Cedex 15, France
    Br J Haematol 115:831-44. 2001
  2. ncbi request reprint Idiotype-pulsed dendritic cells are able to induce antitumoral cytotoxic CD8 cells in chronic lymphocytic leukaemia
    Françoise Vuillier
    Unité d Immuno Hématologie et d Immunopathologie, Institut Pasteur, Paris, France
    Br J Haematol 120:243-50. 2003
  3. ncbi request reprint Monocyte-derived dendritic cells in chronic lymphocytic leukemia
    Françoise Vuillier
    Unité d Immuno Hématologie et d Immunopathologie, Institut Pasteur, 28 rue du Dr Roux, F 75724 Paris Cedex 15, France
    Leuk Lymphoma 44:1267-73. 2003
  4. ncbi request reprint Lower levels of surface B-cell-receptor expression in chronic lymphocytic leukemia are associated with glycosylation and folding defects of the mu and CD79a chains
    Françoise Vuillier
    Unité d Immuno Hématologie et d Immunopathologie, Plate forme de Microscopie Electronique, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris Cedex 15, France
    Blood 105:2933-40. 2005
  5. ncbi request reprint Different isoforms of BSAP regulate expression of AID in normal and chronic lymphocytic leukemia B cells
    Pablo Oppezzo
    Unité d Immuno Hématologie et d Immunopathologie, Institut Pasteur, 28 rue Docteur Roux, 75015 Paris, France
    Blood 105:2495-503. 2005
  6. ncbi request reprint Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation
    Pablo Oppezzo
    Unité d Immuno Hématologie et d Immunopathologie, Institut Pasteur, Paris, France
    Blood 101:4029-32. 2003
  7. ncbi request reprint [Cell therapy by dendritic cells in chronic lymphoid leukemia: state of the art]
    Françoise Vuillier
    Unité d Immuno Hématologie et d Immunopathologie, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris, France
    Bull Cancer 90:744-50. 2003
  8. ncbi request reprint The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia
    Pablo Oppezzo
    Unité d Immuno Hématologie et d Immunopathologie, Institut Pasteur, Paris, France
    Blood 106:650-7. 2005

Collaborators

  • Daniel Scott-Algara
  • Evie Melanitou
  • G Dighiero
  • Pablo Oppezzo
  • Gérard Dumas
  • Christian Magnac
  • Otto Pritsch
  • Yuri Vasconcelos
  • Beatrice Payelle-Brogard
  • Catherine Settegrana
  • Frederic Davi
  • Martine Brissard
  • Magali Legarff-Tavernier
  • Ana Inés Lalanne
  • Stephane Bechet
  • Eliza Yuriko Kimura
  • Hélène Merle-Béral
  • Mihoko Yamamoto
  • Dominique Jeannel

Detail Information

Publications8

  1. ncbi request reprint Functional monocyte-derived dendritic cells can be generated in chronic lymphocytic leukaemia
    F Vuillier
    Unité d Immuno Hématologie et d Immunopathologie, Institut Pasteur, 28 rue du Dr Roux, F 75724 Paris Cedex 15, France
    Br J Haematol 115:831-44. 2001
    ..Overall, these results indicate that it is possible to derive functionally competent DCs from circulating monocytes in CLL patients...
  2. ncbi request reprint Idiotype-pulsed dendritic cells are able to induce antitumoral cytotoxic CD8 cells in chronic lymphocytic leukaemia
    Françoise Vuillier
    Unité d Immuno Hématologie et d Immunopathologie, Institut Pasteur, Paris, France
    Br J Haematol 120:243-50. 2003
    ..The failure of cytolytic activity in patients with aggressive disease may be explained by a skewed maturation of memory CD8 cells...
  3. ncbi request reprint Monocyte-derived dendritic cells in chronic lymphocytic leukemia
    Françoise Vuillier
    Unité d Immuno Hématologie et d Immunopathologie, Institut Pasteur, 28 rue du Dr Roux, F 75724 Paris Cedex 15, France
    Leuk Lymphoma 44:1267-73. 2003
    ..After summarizing general properties of dendritic cells, this review focus on the approaches exploiting monocyte-derived dendritic cells in CLL, which should help design of novel treatment strategies in this disease...
  4. ncbi request reprint Lower levels of surface B-cell-receptor expression in chronic lymphocytic leukemia are associated with glycosylation and folding defects of the mu and CD79a chains
    Françoise Vuillier
    Unité d Immuno Hématologie et d Immunopathologie, Plate forme de Microscopie Electronique, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris Cedex 15, France
    Blood 105:2933-40. 2005
    ..These data show, for the first time, that lower levels of BCR surface expression observed in CLL are accounted for by an impaired glycosylation and folding of the mu and CD79a chains...
  5. ncbi request reprint Different isoforms of BSAP regulate expression of AID in normal and chronic lymphocytic leukemia B cells
    Pablo Oppezzo
    Unité d Immuno Hématologie et d Immunopathologie, Institut Pasteur, 28 rue Docteur Roux, 75015 Paris, France
    Blood 105:2495-503. 2005
    ..Overall, these results suggest that Pax-5/Delta-Ex8 could play an important role in the control of its own transcription and indirectly in AID expression and CSR...
  6. ncbi request reprint Chronic lymphocytic leukemia B cells expressing AID display dissociation between class switch recombination and somatic hypermutation
    Pablo Oppezzo
    Unité d Immuno Hématologie et d Immunopathologie, Institut Pasteur, Paris, France
    Blood 101:4029-32. 2003
    ..Our results show a dissociation between SHM and CSR in CLL and suggest that, in this disease, AID would require additional help for carrying out the SHM process...
  7. ncbi request reprint [Cell therapy by dendritic cells in chronic lymphoid leukemia: state of the art]
    Françoise Vuillier
    Unité d Immuno Hématologie et d Immunopathologie, Institut Pasteur, 28 rue du Dr Roux, 75724 Paris, France
    Bull Cancer 90:744-50. 2003
    ..After summarizing general properties of dendritic cells, this review focus on the approaches exploiting monocyte-derived dendritic cells in CLL, which should help design of novel treatment strategies in this disease...
  8. ncbi request reprint The LPL/ADAM29 expression ratio is a novel prognosis indicator in chronic lymphocytic leukemia
    Pablo Oppezzo
    Unité d Immuno Hématologie et d Immunopathologie, Institut Pasteur, Paris, France
    Blood 106:650-7. 2005
    ..Overall, quantification of LPL and ADAM29 gene expression is a strong prognostic indicator in CLL, providing better prognostic assessment than ZAP-70 in advanced stages of the disease...